Colon Cancer - Bristol-Myers Profit Falls 4.2% on Restructure Costs (Update6) - Bloomberg
Bristol-Myers Profit Falls 4.2% on Restructure Costs (Update6) - Bloomberg
April 24 (Bloomberg) — Bristol-Myers Squibb Co. ’s first- quarter profit fell 4.2 percent as restructuring expenses offset soaring sales of its blood thinner Plavix. The company said it will sell part of its infant-formula unit to raise cash. Net
High-tech tool makes inroads in valley as demand for it grows - Modesto Bee
Cancer patients like Bruce Hansen of Modesto are being treated with the aid of ever more sophisticated imaging technology. Last week, Hansen, 43, underwent a 24-minute PET/CT scan, which produced an image of a mass on his lung and looked for other
Therapies of tomorrow in trials today - HULIQ.com
Studies presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics demonstrate the flexibility of targeted therapy techniques, where new drugs can be developed and tested in human trials more quickly and
Latest News - dBusinessNews.com
BIG Metrics Provides Competitive Advantage To Community Banks Solution Delivers More Insight Into Profitability, Lending and Deposit Gathering SAN Mediasmith To Be SEGA of America’s Media Agency for Print and Digital SAN FRANCISCO